Q: What is the difference between CDC and WHO growth charts for children?

The CDC and WHO growth charts are both widely used but differ in their derivation, scope, and clinical applications. The CDC 2000 growth charts were developed from data collected across multiple National Health and Nutrition Examination Survey (NHANES) cycles representing the US population between 1963 and 1994. They are intended as a reference — describing how children in the US have grown — rather than a prescriptive standard of ideal growth. The CDC recommends these charts for children ages 2 to 20 years and for clinical use in the United States. The WHO Multicentre Growth Reference Study (MGRS) charts, published in 2006, were derived from a carefully selected sample of healthy breastfed children from diverse countries (Brazil, Ghana, India, Norway, Oman, and the United States) raised in optimal conditions with no nutritional or environmental limitations. They are intended as a prescriptive standard — describing how children should grow when their needs are optimally met. The WHO charts are recommended by the CDC for US children under 2 years of age and internationally for children up to 5 years. A key practical difference is that the WHO charts identify a higher prevalence of overweight in infants and a lower prevalence of underweight compared to the CDC charts, potentially affecting early childhood nutrition screening. For ages 2-5, the two chart sets are frequently used interchangeably but may produce different percentile assignments for the same child.

Q: At what BMI percentile is a child considered obese and what are the health risks?

Children at or above the 95th percentile for BMI-for-age-and-sex are classified as obese by CDC criteria. This threshold was selected because it corresponds approximately to adult BMI of 30 at age 18 on growth chart projections. The American Academy of Pediatrics has further refined the classification into Class I obesity (95th to below 120% of the 95th percentile), Class II obesity (120% to below 140% of the 95th percentile), and Class III severe obesity (140% or above the 95th percentile or absolute BMI ≥ 40), reflecting the growing recognition that severity matters for comorbidity risk and treatment intensity. Health risks associated with childhood obesity include metabolic complications such as type 2 diabetes, insulin resistance, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD); cardiovascular complications including hypertension and left ventricular hypertrophy; orthopedic problems such as Blount disease and slipped capital femoral epiphysis; sleep-disordered breathing and obstructive sleep apnea; and significant psychosocial consequences including depression, anxiety, and disordered eating. Children with Class II-III obesity have substantially higher rates of these complications and are at increased risk for adult cardiovascular disease, type 2 diabetes, and premature mortality. The 2023 AAP Clinical Practice Guideline for the Evaluation and Treatment of Children with Obesity recommends early, intensive, structured intervention rather than watchful waiting, representing a significant shift from previous approaches.

Q: How should BMI percentile results be communicated to families?

Communicating pediatric BMI percentile results to families requires sensitivity, accuracy, and a strengths-based approach. The term "obese" carries significant stigma and can be harmful to children's psychological wellbeing and the therapeutic relationship. The 2023 AAP guideline recommends that clinicians use motivational interviewing techniques, avoid weight stigma and blaming language, and focus on health behaviors rather than weight. When communicating results, clinicians should use specific clinical terminology ("your child's BMI is at the 92nd percentile, in the overweight range") while framing the discussion around health and wellbeing rather than appearance. Parents should understand that BMI percentile is a screening tool, not a diagnosis — a child at the 86th percentile may be muscular rather than overfat, and additional assessment is needed. Sharing the growth chart trajectory visually (showing the trend over time) is often more informative and less alarming than a single data point. The conversation should explore the family's values, barriers to healthy eating and activity, and resources available. Weight shaming or negative comments about a child's body have been shown to increase the risk of disordered eating and poor mental health outcomes. Cultural context matters — BMI reference charts were derived from predominantly white populations, and Asian and Asian-American children may have higher cardiometabolic risk at lower BMI percentiles, warranting lower thresholds for metabolic screening in some guidelines.

Q: When should children with high BMI percentiles be referred to a specialist?

Referral thresholds for pediatric obesity management have been updated in the 2023 AAP Clinical Practice Guideline on Childhood Obesity. All children with obesity (BMI ≥ 95th percentile) should receive evidence-based intensive health behavior and lifestyle treatment (IHBLT) — defined as 26 or more hours of face-to-face, multicomponent intervention over 3-12 months — as the first-line treatment in primary care where available. Referral to a pediatric obesity medicine specialist, multidisciplinary clinic, or academic center is indicated for: Class II or III obesity (≥ 120% of the 95th percentile); obesity with significant comorbidities including type 2 diabetes, non-alcoholic steatohepatitis, significant hypertension, severe obstructive sleep apnea, Blount disease, or slipped capital femoral epiphysis; failure to respond to primary care lifestyle intervention; suspected secondary causes of obesity (hypothyroidism, Cushing syndrome, Prader-Willi syndrome, genetic obesity syndromes); or consideration of pharmacotherapy (orlistat, liraglutide, semaglutide recently approved for adolescents) or metabolic and bariatric surgery in adolescents ≥ 13 years with Class III obesity and comorbidities. The AAP 2023 guideline for the first time recommends offering pharmacotherapy and surgery as appropriate components of a treatment approach, representing a significant departure from previous guidelines that emphasized lifestyle alone.

Question 1

Why is BMI interpreted as a percentile in children rather than as an absolute value?

Accepted Answer

In adults, fixed BMI thresholds define underweight (< 18.5), normal weight (18.5-24.9), overweight (25-29.9), and obesity (≥ 30) because adult body composition and height are relatively stable. In children, both height and body composition change dramatically with age and differ between sexes, making fixed BMI thresholds inappropriate. A BMI of 18 is normal for a 10-year-old but indicative of underweight for a 17-year-old. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) therefore use sex-specific-for-age growth charts derived from large representative population samples to define normal BMI ranges. Percentiles indicate where a child's BMI falls relative to other children of the same age and sex. The CDC defines weight categories for children ages 2-20 as follows: underweight is BMI below the 5th percentile; healthy weight is 5th to below the 85th percentile; overweight is 85th to below the 95th percentile; and obese is at or above the 95th percentile. The American Academy of Pediatrics also recognizes severe obesity as BMI at or above 120% of the 95th percentile for age and sex (approximately the 99th percentile), which identifies children at highest risk for severe comorbidities requiring intensive intervention. Percentile interpretation is essential because it adjusts for the normal growth trajectory at each age.

Question 2

What is the difference between CDC and WHO growth charts for children?

Accepted Answer

The CDC and WHO growth charts are both widely used but differ in their derivation, scope, and clinical applications. The CDC 2000 growth charts were developed from data collected across multiple National Health and Nutrition Examination Survey (NHANES) cycles representing the US population between 1963 and 1994. They are intended as a reference — describing how children in the US have grown — rather than a prescriptive standard of ideal growth. The CDC recommends these charts for children ages 2 to 20 years and for clinical use in the United States. The WHO Multicentre Growth Reference Study (MGRS) charts, published in 2006, were derived from a carefully selected sample of healthy breastfed children from diverse countries (Brazil, Ghana, India, Norway, Oman, and the United States) raised in optimal conditions with no nutritional or environmental limitations. They are intended as a prescriptive standard — describing how children should grow when their needs are optimally met. The WHO charts are recommended by the CDC for US children under 2 years of age and internationally for children up to 5 years. A key practical difference is that the WHO charts identify a higher prevalence of overweight in infants and a lower prevalence of underweight compared to the CDC charts, potentially affecting early childhood nutrition screening. For ages 2-5, the two chart sets are frequently used interchangeably but may produce different percentile assignments for the same child.

Question 3

At what BMI percentile is a child considered obese and what are the health risks?

Accepted Answer

Children at or above the 95th percentile for BMI-for-age-and-sex are classified as obese by CDC criteria. This threshold was selected because it corresponds approximately to adult BMI of 30 at age 18 on growth chart projections. The American Academy of Pediatrics has further refined the classification into Class I obesity (95th to below 120% of the 95th percentile), Class II obesity (120% to below 140% of the 95th percentile), and Class III severe obesity (140% or above the 95th percentile or absolute BMI ≥ 40), reflecting the growing recognition that severity matters for comorbidity risk and treatment intensity. Health risks associated with childhood obesity include metabolic complications such as type 2 diabetes, insulin resistance, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD); cardiovascular complications including hypertension and left ventricular hypertrophy; orthopedic problems such as Blount disease and slipped capital femoral epiphysis; sleep-disordered breathing and obstructive sleep apnea; and significant psychosocial consequences including depression, anxiety, and disordered eating. Children with Class II-III obesity have substantially higher rates of these complications and are at increased risk for adult cardiovascular disease, type 2 diabetes, and premature mortality. The 2023 AAP Clinical Practice Guideline for the Evaluation and Treatment of Children with Obesity recommends early, intensive, structured intervention rather than watchful waiting, representing a significant shift from previous approaches.

Question 4

How should BMI percentile results be communicated to families?

Accepted Answer

Communicating pediatric BMI percentile results to families requires sensitivity, accuracy, and a strengths-based approach. The term "obese" carries significant stigma and can be harmful to children's psychological wellbeing and the therapeutic relationship. The 2023 AAP guideline recommends that clinicians use motivational interviewing techniques, avoid weight stigma and blaming language, and focus on health behaviors rather than weight. When communicating results, clinicians should use specific clinical terminology ("your child's BMI is at the 92nd percentile, in the overweight range") while framing the discussion around health and wellbeing rather than appearance. Parents should understand that BMI percentile is a screening tool, not a diagnosis — a child at the 86th percentile may be muscular rather than overfat, and additional assessment is needed. Sharing the growth chart trajectory visually (showing the trend over time) is often more informative and less alarming than a single data point. The conversation should explore the family's values, barriers to healthy eating and activity, and resources available. Weight shaming or negative comments about a child's body have been shown to increase the risk of disordered eating and poor mental health outcomes. Cultural context matters — BMI reference charts were derived from predominantly white populations, and Asian and Asian-American children may have higher cardiometabolic risk at lower BMI percentiles, warranting lower thresholds for metabolic screening in some guidelines.

Question 5

When should children with high BMI percentiles be referred to a specialist?

Accepted Answer

Referral thresholds for pediatric obesity management have been updated in the 2023 AAP Clinical Practice Guideline on Childhood Obesity. All children with obesity (BMI ≥ 95th percentile) should receive evidence-based intensive health behavior and lifestyle treatment (IHBLT) — defined as 26 or more hours of face-to-face, multicomponent intervention over 3-12 months — as the first-line treatment in primary care where available. Referral to a pediatric obesity medicine specialist, multidisciplinary clinic, or academic center is indicated for: Class II or III obesity (≥ 120% of the 95th percentile); obesity with significant comorbidities including type 2 diabetes, non-alcoholic steatohepatitis, significant hypertension, severe obstructive sleep apnea, Blount disease, or slipped capital femoral epiphysis; failure to respond to primary care lifestyle intervention; suspected secondary causes of obesity (hypothyroidism, Cushing syndrome, Prader-Willi syndrome, genetic obesity syndromes); or consideration of pharmacotherapy (orlistat, liraglutide, semaglutide recently approved for adolescents) or metabolic and bariatric surgery in adolescents ≥ 13 years with Class III obesity and comorbidities. The AAP 2023 guideline for the first time recommends offering pharmacotherapy and surgery as appropriate components of a treatment approach, representing a significant departure from previous guidelines that emphasized lifestyle alone.

Pediatric BMI Percentile Calculator

BMI Assessment

Clinical Guidance

How to Use This Calculator

Formula

Example

Frequently Asked Questions

Related Calculators